PRQR (ProQR Therapeutics N.V. Ordinary Shares) Stock Analysis - Insider Trades

ProQR Therapeutics N.V. Ordinary Shares (PRQR) is a publicly traded Healthcare sector company. As of May 21, 2026, PRQR trades at $1.51 with a market cap of $159.10M and a P/E ratio of 0.00. PRQR moved +0.00% today. Year to date, PRQR is -29.90%; over the trailing twelve months it is -18.75%. Its 52-week range spans $1.07 to $4.62. Analyst consensus is strong buy with an average price target of $8.20. Rallies surfaces PRQR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading PRQR stock inside the company?

Rallies tracks PRQR insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.

PRQR Key Metrics

Key financial metrics for PRQR
MetricValue
Price$1.51
Market Cap$159.10M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$4.62
52-Week Low$1.07
Volume0
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest PRQR News

PRQR Analyst Consensus

5 analysts cover PRQR: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $8.20.

Common questions about PRQR

Who is trading PRQR stock inside the company?
Rallies tracks PRQR insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
Does Rallies show Form 4 insider transactions for PRQR?
Yes. Rallies tracks PRQR insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is PRQR research on Rallies investment advice?
No. Rallies provides research, data, and educational context for PRQR. It does not provide personalized investment advice.
PRQR

PRQR